Case Study: Global Pharmaceuticals Company prevents $130M in duplicate payments with apexanalytix firststrike

Global Pharmaceuticals Using technology-based controls to protect, analyze and manage accounts payable

Global Pharmaceuticals Company, a global pharmaceutical manufacturer with more than 40,000 employees and operations in dozens of locations worldwide, needed stronger controls for a highly transaction-intensive procure-to-pay environment. With four regional shared services centers processing about 5 million invoices a year from 130,000 suppliers, the company wanted a global duplicate payment prevention tool that would offer more protection than the controls in its SAP platform. apexanalytix and its firststrike® software were selected to address this challenge.

apexanalytix implemented firststrike® in just 90 days, giving the company advanced duplicate payment prevention, fraud detection, vendor management, reporting, and analytics. The results were substantial: over $130 million in duplicate payments was prevented over three years, thousands of historical duplicates were identified, outside audit recovery fees fell by about 75% annually, and the company gained better root-cause analysis and global reporting with far less manual effort.